Assignee
ALMAC DISCOVERY LTD
GB·10 granted patents·11 pending applications·18 citations·filing 2013–2025
Top patents by PatentIndex Score
21 records- 0184US11053213B2Pharmaceutical compoundsALMAC DISCOVERY LTD·Filed 2017·Granted Jul 6, 2021·5 cites·21 claims
- 0283US9850247B2Pyrimidopyrimidinones useful as Wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2014·Granted Dec 26, 2017·5 cites·20 claims
- 0377US10766903B2Piperidine derivatives as inhibitors of ubiquitin specific protease 7ALMAC DISCOVERY LTD·Filed 2017·Granted Sep 8, 2020·3 cites·22 claims
- 0475US11208413B2Pyrimidopyrimidinones useful as wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2018·Granted Dec 28, 2021·1 cites·12 claims
- 0569US9714244B2Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitorsALMAC DISCOVERY LTD·Filed 2014·Granted Jul 25, 2017·2 cites·11 claims
- 0669US2025295767A1Ror1-specific antigen binding moleculesALMAC DISCOVERY LTD·Filed 2025·Application pending·0 cites
- 0768US9156853B2AKT inhibitor compounds for treatment of cancerALMAC DISCOVERY LTD·Filed 2013·Granted Oct 13, 2015·1 cites·23 claims
- 0867US11807646B24-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)ALMAC DISCOVERY LTD·Filed 2019·Granted Nov 7, 2023·1 cites·15 claims
- 0961US12466805B2Pharmaceutical compoundsALMAC DISCOVERY LTD·Filed 2021·Granted Nov 11, 2025·0 cites·22 claims
- 1060US2022194947A1Pyrimidopyrimidinones useful as wee-1 kinase inhibitorsALMAC DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1156US2025122223A1Heterocyclic compounds as ubiquitin specific protease 7 inhibitorsALMAC DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 1256US2025375530A1Ror1/egfr bi-specific antigen binding moleculesALMAC DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 1353US2024327382A1Pharmaceutical compounds as inhibitors of ubiquitin specific protease 19ALMAC DISCOVERY LTD·Filed 2022·Application pending·0 cites
- 1449US2025269051A1Ror1-specific variant antigen binding moleculesALMAC DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1548US2023088286A1Usp7 inhibitor for use in the treatment of cancerALMAC DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1645US10577406B2FKBP-L polypeptides and uses in angiogenesis-mediated disordersALMAC DISCOVERY LTD·Filed 2016·Granted Mar 3, 2020·0 cites·46 claims
- 1741US2022016115A1Usp19 inhibitors for use in therapyALMAC DISCOVERY LTD·Filed 2019·Application pending·0 cites
- 1839US2022033397A1Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)ALMAC DISCOVERY LTD·Filed 2019·Application pending·0 cites
- 1939US2023241072A1Anthracycline derivativesALMAC DISCOVERY LTD·Filed 2020·Application pending·0 cites
- 2036US10766902B2Wee-1 inhibiting pyrazolopyrimidinone compoundsALMAC DISCOVERY LTD·Filed 2017·Granted Sep 8, 2020·0 cites·26 claims
- 2126US2019231847A1Treatment of ocular diseaseALMAC DISCOVERY LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →